| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $350.2M | +13.0% | +48.3% |
| Cost of Revenue | $68.1M | +7.2% | +21.4% |
| Gross Profit | $282.0M | +14.5% | +56.7% |
| R&D Expense | $97.6M | +5.9% | +21.9% |
| SG&A Expense | $66.8M | +0.2% | +1.4% |
| Operating Income | -$75.5M | +20.1% | +39.5% |
| Interest Expense | $1.1M | -79.4% | -89.5% |
| Pre-tax Income | -$60.9M | +35.2% | +52.7% |
| Income Tax | $2.9M | +57.4% | +48.5% |
| Net Income | -$63.8M | +33.5% | +51.2% |
| EPS (Basic) | -$0.32 | +34.7% | +54.9% |
| EPS (Diluted) | -$0.32 | +34.7% | +54.9% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $307.1M | -4.8% | +195.6% |
| Accounts Receivable | $219.7M | +1.2% | +48.8% |
| Inventory | $5.3M | +6.0% | +30.2% |
| Current Assets | $2.07B | +7.1% | +119.0% |
| Total Assets | $2.55B | +6.7% | +100.9% |
| Current Liabilities | $1.16B |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $189.9M | — | — |
| Capital Expenditures | $11.1M | — | — |
| Investing Cash Flow | -$811.5M | — | — |
| Financing Cash Flow | $736.0M | — | — |
| Free Cash Flow | $178.8M | — | — |
| +42.4% |
| Total Liabilities | $3.07B | +4.1% | +71.7% |
| Stockholders' Equity | -$524.4M | +7.1% | -0.6% |